X0202 SCHEDULE 13G/A 0001846412 XXXXXXXX LIVE 1 Ordinary Shares, no par value per share 06/30/2026 0001075880 Kazia Therapeutics Limited 48669G303 Three International Towers Level 24 300 Barangaroo Avenue Sydney, New South Wales C3 2000 Rule 13d-1(c) Lynwood Capital Management Inc. A6 264980500.00 0.00 264980500.00 0.00 264980500.00 N 4.6 CO Ben Shapiro Z4 264980500.00 0.00 264980500.00 0.00 264980500.00 N 4.6 IN Lynwood Opportunities Master Fund E9 264980500.00 0.00 264980500.00 0.00 264980500.00 N 4.6 OO Kazia Therapeutics Limited Three International Towers Level 24, 300 Barangaroo Avenue, Sydney, New South Wales, Australia, 2000 This Schedule 13G (this "Statement" or this "Schedule 13G") is being filed by: (1) Lynwood Capital Management Inc., an Ontario corporation (the "Investment Manager"); (2) Ben Shapiro ("Mr. Shapiro"); and (3) Lynwood Opportunities Master Fund, a Cayman Islands entity (the "Fund") (all of the foregoing, collectively, the "Reporting Persons"). The Fund is an investment vehicle. The Fund directly beneficially owns the Ordinary Shares (as defined below) reported in this Statement. The Investment Manager is the investment manager of the Fund. Mr. Shapiro is the President, Chief Executive Officer, Chief Investment Officer, sole director and indirect controlling stockholder of the Investment Manager. Mr. Shapiro and the Investment Manager may be deemed to beneficially own the Ordinary Shares directly beneficially owned by the Fund. Each Reporting Person disclaims beneficial ownership with respect to any Ordinary Shares other than the Ordinary Shares directly beneficially owned by such Reporting Person. The principal business office of the Fund is FG Services Limited, Suite 2206, Cassia Court, 72 Market Street, Camana Bay, P.O. Box 30869, Grand Cayman KY1-1204, Cayman Islands. The principal business office of the Investment Manager and Mr. Shapiro is 200 Bay St, Suite 1304, Royal Bank Plaza, South Tower, Toronto, Ontario M5J 2J1. For citizenship or place of organization see Item 4 of the cover page of each Reporting Person. Y See Item 9 on the cover page for each Reporting Person, and Item 2, which information is given as of the close of business on June 30, 2026, the Date of Event which requires the filing of this Schedule 13G. The Reporting Persons own Ordinary Shares through the Issuer's American Depositary Shares, each representing five hundred (500) Ordinary Shares. The Ordinary Shares have no CUSIP number. The CUSIP number for the Issuer's American Depositary Shares is 48669G303. See Item 11 on the cover page for each Reporting Person. The percentages of beneficial ownership contained herein are based on 5,713,449,734 Ordinary Shares outstanding as of March 12, 2026 as reported by the Issuer in a Form F-3 filed with the SEC on March 18, 2026. See Item 5 on the cover page for each Reporting Person. See Item 6 on the cover page for each Reporting Person. See Item 7 on the cover page for each Reporting Person. See Item 8 on the cover page for each Reporting Person. N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Lynwood Capital Management Inc. /s/ Ben Shapiro 08/14/2026 Ben Shapiro /s/ Ben Shapiro 08/14/2026 Lynwood Opportunities Master Fund /s/ Ben Shapiro 08/14/2026